🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine if rituximab administered after allogeneic transplantation dec...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2005-06
Trial ID
NCT00186628
This phase II trial studies how well tacrolimus and mycophenolate mofetil w...
Status
Completed
Location
Huntsman Cancer Institute/University of Utah
Start Date
2004-04
Trial ID
NCT00089011
RATIONALE: Giving low doses of chemotherapy, such as busulfan and fludarabi...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2011-01-07
Trial ID
NCT00448201
The design of the study incorporates the following features: 1. This is a ...
Status
Withdrawn
Location
UT Southwestern Medical Center
Start Date
2014-01
Trial ID
NCT02038478
Treatments Being Tested
This clinical trial studies fludarabine phosphate, low-dose total-body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1997-08
Trial ID
NCT00003145
This phase I/II trial studies the side effects of giving reduced-intensity ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2002-10
Trial ID
NCT00054353
This phase I trial studies the side effects and best dose of lenalidomide a...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2013-10-07
Trial ID
NCT01954784
RATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and melphala...
Status
Completed
Location
Wake Forest University Comprehensive Cancer Center
Start Date
2007-02
Trial ID
NCT00453206
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and busulf...
Status
Completed
Location
Alta Bates Comprehensive Cancer Center
Start Date
1999-01
Trial ID
NCT00296023
This phase II trial is studying how well fludarabine phosphate and total-bo...
Status
Completed
Location
Presbyterian - Saint Lukes Medical Center - Health One
Start Date
2001-07-13
Trial ID
NCT00036738